Search Within

Aseem Anand

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (8)
Groups
  1. Department of Medicine (21)
  2. Epidemiology and Biostatistics (21)
  3. Genitourinary Oncology Service (21)
  4. Solid Tumor Oncology Division (21)
  5. Biostatistics Service (20)
  6. GSK Faculty (15)

More Groups

People
  1. Howard Scher (21)
  2. Glenn Heller (19)
  3. Daniel Danila (17)
  4. Martin Fleisher (14)
  5. Hans Lilja (9)
  6. Nikolaus Schultz (6)

More People

Years
  1. 2025 (1)
  2. 2022 (1)
  3. 2019 (1)
  4. 2017 (1)
  5. 2016 (1)
  6. 2015 (1)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Clinical Cancer Research (2)
  3. European Urology (2)
  4. Annals of Oncology (1)
  5. Cancer (1)
  6. Clinical Genitourinary Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. American Association for Cancer Research (3)
  3. Elsevier Science, Inc. (2)
  4. Elsevier Inc. (1)
  5. Lippincott Williams & Wilkins (1)
  6. Nature Publishing Group (1)

More Publishers

Results (21)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A novel predictive model using changes in clinical and serum biomarkers and automated quantitative imaging for mCRPC patients treated with AR-directed therapy
    Meeting Abstract

    Morris, M. J.; Flynn, J.; Zhao, B.; Anand, A.; Sjöstrand, K.; Larson, S. M.; Scher, H. I.; Regazzi, A. M.; Borzillo, G. V.; Park, A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Automated bone scan index to optimize prostate cancer working group radiographic progression criteria for men with metastatic castration-resistant prostate cancer
    Journal Article

    Anand, A.; Heller, G.; Fox, J.; Danila, D. C.; Bjartell, A.; Edenbrandt, L.; Larson, S. M.; Scher, H. I.; Morris, M. J.
    Clinical Genitourinary Cancer (2022)

    Fulltext@MSK | Save
  • High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
    Journal Article

    Razavi, P.; Li, B. T.; Brown, D. N.; Jung, B.; Hubbell, E.; Shen, R.; Abida, W.; Juluru, K.; De Bruijn, I.; Hou, C.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • Translating prostate cancer working group (PCWG) criteria into a quantitative progression biomarker in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Anand, A.; Heller, G.; Scher, H. I.; Morris, M. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical validity of detecting circulating tumor cells by AdnaTest assay compared with direct detection of tumor mRNA in stabilized whole blood, as a biomarker predicting overall survival for metastatic castration-resistant prostate cancer patients
    Journal Article

    Danila, D. C.; Samoila, A.; Patel, C.; Schreiber, N.; Herkal, A.; Anand, A.; Bastos, D.; Heller, G.; Fleisher, M.; Scher, H. I.
    The Cancer Journal (2016)

    Fulltext@MSK | Save
  • Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications
    Journal Article

    Rathkopf, D. E.; Larson, S. M.; Anand, A.; Morris, M. J.; Slovin, S. F.; Shaffer, D. R.; Heller, G.; Carver, B.; Rosen, N.; Scher, H. I.
    Cancer (2015)

    Fulltext@MSK | Save
  • Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survival
    Journal Article

    Danila, D. C.; Anand, A.; Schultz, N.; Heller, G.; Wan, M.; Sung, C. C.; Dai, C.; Khanin, R.; Fleisher, M.; Lilja, H.; more...
    European Urology (2014)

    Fulltext@MSK | Save
  • Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D. C.; Anand, A.; Heller, G.; Wan, M.; Herkal, A.; Patel, C.; Khanin, R.; Schultz, N.; Lilja, H.; Fleisher, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Sera cytokine levels to predict survival in men with progressive castration-resistant prostate cancer
    Meeting Abstract

    Subudhi, S. K.; Heller, G.; Danila, D. C.; Anand, A.; Lacuna, K. P.; Samoila, A.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Anand, A.; Danila, D. C.; Heller, G.; Herkal, A.; Patel, C.; Khanin, R.; Schultz, N.; Lilja, H.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save